You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Abscopal

Showing 151 - 166 of 166
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in Frankfurt am Main (Immunostimulating Interstitial Laser Thermotherapy)

Terminated
  • Neoplasms
  • Immunostimulating Interstitial Laser Thermotherapy
  • Frankfurt am Main, Germany
    University Hospital Frankfurt
Jan 29, 2019

Lung Cancer Metastatic Trial in Xiamen (SBRT, Immunological Agent, Immunological Factors)

Unknown status
  • Lung Cancer Metastatic
  • SBRT
  • +2 more
  • Xiamen, Fujian, China
    First affiliated Hospital of Xiamen University
Nov 28, 2016

Tumors Trial in Pamplona, Madrid (Urelumab + Nivolumab)

Unknown status
  • Neoplasms
  • Urelumab + Nivolumab
  • Pamplona, Navarra, Spain
  • +1 more
Jan 2, 2019

Metastatic Melanoma Trial in New York (Ipilimumab, Radiation Therapy)

Terminated
Has Results
  • Metastatic Melanoma
  • New York, New York
    NYU Clinical Cancer Center
Jan 26, 2018

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial run by the NCI (AMP-224, Stereotactic Body Radiation

Completed
Has Results
  • Colorectal Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 12, 2019

Tumors Trial in Pamplona (Hiltonol and autologous dendritic cells, Hiltonol, dendritic cells and radiation)

Completed
  • Neoplasms
  • Hiltonol and autologous dendritic cells
  • Hiltonol, dendritic cells and radiation
  • Pamplona, Navarra, Spain
    Clinica Universidad de Navarra
Apr 10, 2017

Lung Adenocarcinoma Trial in Hangzhou (TKI, Thoracic Hypofractionated Radiotherapy, Thymosin Alpha 1)

Unknown status
  • Lung Adenocarcinoma
  • Hangzhou, Zhejiang, China
    Hangzhou First People's Hospital
Nov 23, 2016

NSCLC Stage IV, Limited Metastatic Disease Trial in Maastricht (drug, radiation, other)

Withdrawn
  • NSCLC Stage IV
  • Limited Metastatic Disease
  • Maastricht, Limburg, Netherlands
    MAASTRO clinic
May 22, 2017

Bladder Cancer Trial in San Francisco (Durvalumab, Tremelimumab, Radiation Therapy)

Withdrawn
  • Bladder Cancer
  • San Francisco, California
    UCSF Helen Diller Family Comprehensive Cancer Center
Oct 17, 2017

NSCLC Trial in Marseille (hypofractionated radiotherapy, nivolumab, Ipilimumab)

Unknown status
  • Non-small Cell Lung Cancer
  • hypofractionated radiotherapy
  • +2 more
  • Marseille, France
    Assistance Publique Hôpitaux de Marseille
Apr 17, 2018

NSCLC, SBRT, GM-CSF Trial in Shanghai (SBRT concurrent with GM-CSF, two-drug chemo containing platinum, including

Unknown status
  • NSCLC
  • +2 more
  • SBRT concurrent with GM-CSF
  • two-drug chemotherapy containing platinum, including carboplatin/Cisplatin + pemetrexed/docetaxel/paclitaxel/etoposide/gemcitabine/vinorelbine/albumin-bound paclitaxel
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 30, 2016

Melanoma Trial in Louisville (A-dmDT390-bisFv(UCHT1) (Resimmune®), Ionizing Radiation)

Terminated
  • Melanoma
  • A-dmDT390-bisFv(UCHT1) (Resimmune®)
  • Ionizing Radiation
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Nov 22, 2016

Rectal Cancer, Chemoradiation Trial in Taichung (Preoperative chemoradiotherapy)

Unknown status
  • Rectal Cancer
  • Chemoradiation
  • Preoperative chemoradiotherapy
  • Taichung, Taiwan
    China Medical University Hospital
Nov 30, 2016

Esophageal Cancer, Metastatic Esophageal Cancer, Apatinib Trial in Hangzhou (Apatinib)

Unknown status
  • Esophageal Cancer
  • +2 more
  • Hangzhou, Zhejiang, China
    Hangzhou Cancer Hospital
Aug 25, 2016

Melanoma Trial in Rockland (MSB0010445 (0.3 milligram per kilogram [mg/kg]), MSB0010445 (1.0 mg/kg), MSB0010445 (1.8 mg/kg))

Terminated
Has Results
  • Melanoma
  • MSB0010445 (0.3 milligram per kilogram [mg/kg])
  • +4 more
  • Rockland, Massachusetts
    Please Contact U.S. Medical Information
Sep 14, 2016

Lymphoma, Non-Hodgkin Trial in Toronto (PET Scan with [18F]Fluoro-2-deoxyglucose (FDG))

Completed
  • Lymphoma, Non-Hodgkin
  • PET Scan with [18F]Fluoro-2-deoxyglucose (FDG)
  • Toronto, Ontario, Canada
    Princess Margaret Hospital
Aug 12, 2010